Laura Herrera‐Hidalgo

Author

Hospital Universitario Virgen del Rocío ORCID

Also Known As

Del Amo, Gema Labrador-Herrera, L Herrera Hidalgo, L Herrera-Hidalgo, L Hidalgo, L. Herrera Hidalgo, L. Herrera-Hidalgo, L. Hidalgo, LAURA HERRERA HIDALGO, Laura Herrera Hidalgo

Publications

486

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen del Rocío Instituto de Biomedicina de Sevilla Hospital Universitario Virgen Macarena Centro de Investigación Biomédica en Red Instituto de Salud Carlos III

About

Laura Herrera‐Hidalgo is an author at Hospital Universitario Virgen del Rocío specializing in pharmacotherapy, pharmacodynamic modeling, and drug monitoring.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	22
2	Pharmacology	1	1	22
3	Drug Monitoring	1	1	22
4	Pharmacodynamic Modeling	1	1	22
5	Pharmacokinetics	1	1	22

Laura Herrera‐Hidalgo

Publications

236

Citations

H-Index

Page 1

	Year	Citations
Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK Laura Herrera‐Hidalgo, Katie L. Hopkins, Belén Gutiérrez‐Gutiérrez, Journal of Antimicrobial Chemotherapy	2013	109
Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy Laura Herrera‐Hidalgo, Luis Eduardo López-Cortés, Rafael Luque‐Márquez, Antimicrobial Agents and Chemotherapy	2020	22
Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application Laura Herrera‐Hidalgo, María Victoria Gil-Navarro, Sujan Dilly Penchala, Journal of Pharmaceutical and Biomedical Analysis Therapeutic Drug MonitoringMedicineSimple Lc–ms/ms MethodDrug MonitoringPharmacotherapy	2020	22
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT Laura Herrera‐Hidalgo, José Manuel Lomas-Cabezas, Luis Eduardo López-Cortés, Journal of Clinical Medicine	2021	20
Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial María Trujillo‐Rodríguez, Esperanza Muñoz‐Muela, Ana Serna‐Gallego, Clinical Microbiology and Infection	2022	16
Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs? Laura Herrera‐Hidalgo, Arístides de Alarcón, Luis Eduardo López-Cortés, Antimicrobial Agents and Chemotherapy	2020	13
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy Beatriz Fernández-Rubio, Laura Herrera‐Hidalgo, Arístides de Alarcón, Pharmaceutics	2023	13
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort Laura Herrera‐Hidalgo, Patricia Muñóz, Ana Álvarez‐Uría, International Journal of Infectious Diseases	2023	11
Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy Beatriz Fernández-Rubio, Laura Herrera‐Hidalgo, Rafael Luque‐Márquez, Antibiotics	2023	10

Page 1